l 640035 has been researched along with hydralazine in 1 studies
| Studies (l 640035) | Trials (l 640035) | Recent Studies (post-2010) (l 640035) | Studies (hydralazine) | Trials (hydralazine) | Recent Studies (post-2010) (hydralazine) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 4,580 | 364 | 393 |
| Protein | Taxonomy | l 640035 (IC50) | hydralazine (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 1.265 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.649 | |
| Lactoperoxidase | Bos taurus (cattle) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, CC; Ford-Hutchinson, A | 1 |
1 other study(ies) available for l 640035 and hydralazine
| Article | Year |
|---|---|
Potentiation of the inhibitory effect of a thromboxane A2 antagonist (L-640,035) on arterial thrombosis formation in rabbit by the angiotensin converting enzyme inhibitor enalapril.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Dibenzothiepins; Dipeptides; Drug Synergism; Enalapril; Female; Hexamethonium Compounds; Hydralazine; Male; Prostaglandin Antagonists; Rabbits; Radioimmunoassay; Thrombosis; Thromboxane A2; Thromboxanes | 1985 |